Natchaug Hospital Sachem House

Type of Care

Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Outpatient Partial hospitalization/day treatment

Facility Type

Partial hospitalization/day treatment

Pharmacotherapies

Chlorpromazine Droperidol Fluphenazine Haloperidol Loxapine Perphenazine Pimozide Prochlorperazine Thiothixene Thioridazine Trifluoperazine Aripiprazole Brexpiprazole Cariprazine Clozapine IIoperidone Lurasidone Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI

Treatment Approaches

Activity therapy Cognitive behavioral therapy Dialectical behavior therapy Group therapy Integrated Mental and Substance Use Disorder treatment Telemedicine/telehealth therapy Abnormal involuntary movement scale

Facility Operation (e.g., Private, Public)

Private non-profit organization

Payment/Insurance/Funding Accepted

Medicare Medicaid Federal military insurance (e.g., TRICARE) Private health insurance Cash or self-payment State-financed health insurance plan other than Medicaid State mental health agency (or equivalent) funds

Special Programs/Groups Offered

Young adults Seniors or older adults Clients with co-occurring mental and substance use disorders Persons 18 and older with serious mental illness (SMI)

Assessment/Pre-treatment

Screening for tobacco use

Testing

Metabolic syndrome monitoring Laboratory testing

Education and Counseling Services

Smoking/vaping/tobacco cessation counseling

Facility Smoking Policy

Smoking not permitted

Age Groups Accepted

Young Adults Seniors

Facility Vaping Policy

Vaping not permitted

Ancillary Services

Family psychoeducation Case management service Suicide prevention services